Location: Home
  • search
  • go
  • Relate News
  • 2/14/2023CDE Issues the Technical Guidelines for Research on Quality Attributes...
  • 2/14/2023CDE Seeks Comments on Draft ICH Guidelines M13A
  • 2/14/2023Hengrui and Treeline Enter $706M Licensing Deal for EZH2 inhibitor SHR...
  • 2/14/2023Cullinan and HBM Sign Licensing Deal for B7H4 x 4-1BB Bispecific Immu...
  • 2/14/2023CDE Issues the Guidelines for Clinical Evaluation of Radioactive In Vi...
  • 2/13/2023Nona Biosciences Enters into HCAb Based Antibody Discovery Collaborati...
  • 2/13/2023Lantheus Acquires Cerveau and Its Tau-spotting PET Tracer for Alzheime...
  • 2/13/2023CDE Issues the Guidelines for Clinical Development of New Drugs for Ac...
  • 2/13/2023CDE Issues the Guidelines for Clinical Trials of Drug Therapies for Pr...
  • 2/13/2023CDE Issues the Guidelines for Pharmaceutical Study and Assessment of O...
  • 2/13/2023Corbus Licenses Clinical Stage Nectin-4 Targeting ADC from CSPC Megal...
  • 2/13/2023Clover Launches COVID-19 Booster Vaccine in China
  • 2/10/2023China Drug Sales Performance of Top Seven MNC Pharma Cos in 2022
  • 2/10/2023Recent Executive Moves
  • 2/10/2023Drug R&D and Product Registration News Digest February 2023 (2)
  • 2/10/2023Six Central Government Agencies Introduce the Work Plan for Trial of C...
  • 2/10/2023U.S. Aims to Curtail Technology Investment in China (NYT)
  • 2/9/2023Facing Multiple Challenges, What Are the Clinical Development Trends i...
  • 2/9/2023With China's Re-opening: Staying Ahead of FDA Drug cGMP Enforcement (G...
  • 2/9/2023It Is Now More Difficult For International Pharma To Transfer Data Out...
  • 2/9/2023Amid Scarcity and Soaring Prices, China Could Issues Compulsory Licens...
  • 2/8/2023After Ditching Promising Drug, Everest Medicines Bets on mRNA (The Bam...
  • 2/8/2023ReviR and Asieris Enter into Agreement to Discover Oncology Therapeut...
  • 2/7/2023New-Generation Long-Acting Growth Hormone Is A Potential Game Changer ...
  • 2/7/2023China's 2022 NRDL Readout (PharmExec)
  • 2/6/2023Ji Xing Acquires Global Rights of PhaseBio's CVD Drug PB6440
  • 2/3/2023Recent Executive Moves
  • 2/3/2023Drug R&D and Product Registration News Digest February 2023 (1)
  • 2/2/2023NMPA Holds National Drug Registration and Post-Marketing Supervision C...
  • 2/2/2023Huawei to Build First Digital Robot for Pharmaceutical Industry
  • Page:56/719 Total number of articles:21546: [First][<<] [54] [55] [56] [57] [58] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group